wound care

Dallas’ Spectral AI Appoints Chief Commercialization Officer

by | May 31, 2024

Dallas-based artificial intelligence company Spectral AI Inc. has appointed Jeremiah A. Sparks as chief commercialization officer. Spectral AI focuses on medical diagnostics for faster and more accurate treatment decisions in wound care.

Sparks brings over 20 years of medical device marketing experience, including global marketing and business strategy. He will be responsible for both domestic and international product commercialization, the company said....

MORE
Spectral AI Names CEO of Its IP-Focused Subsidiary, Explores Spin Off
by | Apr 26, 2024
The largest investor in Spectral AI, Erich Spangenberg, has extensive expertise in intellectual property investment management.
MORE
Spectral AI Names Former Top MiMedx Financial Exec as CFO
by | Dec 27, 2023

Seasoned financial executive Peter M. Carlson has been hired as chief financial officer of Dallas-based Spectral AI Inc., an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care....

MORE
Spectral AI Appoints Chairman of Board’s Executive Committee
by | Dec 1, 2023

Dallas-based predictive artificial intelligence company Spectral AI Inc. announced that Erich Spangenberg has been appointed to the company’s board of directors and named chairman of its executive committee.

Spectral AI focuses on medical diagnostics for faster and more accurate treatment decisions in clinical wound care.

“We are pleased to welcome the return of Erich to the board of directors, where his experience, insights and network will be an invaluable resource for our company,” Spectral AI CEO Wensheng Fan said in a statement....

MORE

Spectral AI Appoints ‘High-Impact’ Healthcare Exec to its Board of Directors

by | Oct 6, 2023
In September, the firm began trading on Nasdaq and secured a BARDA Project BioShield contract worth up to $149 million.
MORE